California Public Employees Retirement System’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-38,363
Closed -$1.58M 1639
2021
Q1
$1.58M Sell
38,363
-4,534
-11% -$270K ﹤0.01% 2184
2020
Q4
$1.86M Buy
42,897
+6,249
+17% +$423K ﹤0.01% 2036
2020
Q3
$1.57M Buy
36,648
+7,216
+25% +$358K ﹤0.01% 1961
2020
Q2
$1.38M Buy
+29,432
New +$1.01M ﹤0.01% 2010
2017
Q4
Sell
-7,286
Closed -$52K 3317
2017
Q3
$52K Hold
7,286
﹤0.01% 3237
2017
Q2
$57K Hold
7,286
﹤0.01% 3262
2017
Q1
$58K Hold
7,286
﹤0.01% 3288
2016
Q4
$107K Hold
7,286
﹤0.01% 3217
2016
Q3
$126K Hold
7,286
﹤0.01% 3217
2016
Q2
$229K Hold
7,286
﹤0.01% 3085
2016
Q1
$193K Hold
7,286
﹤0.01% 3154
2015
Q4
$320K Hold
7,286
﹤0.01% 3007
2015
Q3
$308K Hold
7,286
﹤0.01% 3032
2015
Q2
$334K Hold
7,286
﹤0.01% 3082
2015
Q1
$343K Hold
7,286
﹤0.01% 3173
2014
Q4
$343K Buy
+7,286
New +$232K ﹤0.01% 3173

Other funds holding ARCT

California Public Employees Retirement System's ARCT Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Arcturus Therapeutics (ARCT) in Q2 2021, closing a stake of 38,363 shares — an estimated $1.58M sold.

California Public Employees Retirement System first reported a position in ARCT in Q4 2014 and held it in 16 quarters. The position peaked at $1.86M in Q4 2020. 139 funds tracked by Wall St. Rank hold ARCT as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Arcturus Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 38,363 Arcturus Therapeutics shares in Q2 2021, an estimated $1.58M.
  • California Public Employees Retirement System first reported a position in Arcturus Therapeutics in Q4 2014 and held it in 16 quarters.
  • California Public Employees Retirement System's Arcturus Therapeutics position peaked at $1.86M in Q4 2020.
  • 139 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.